Skip to main content

Advertisement

SpringerLink
Log in

CPAP adherence and cardiovascular disease: beware of the healthy adherer effect

  • Sleep Breathing Physiology and Disorders • Letter to the Editors
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Myllylä M, Hammais A, Stepanov M, Anttalainen U, Saaresranta T, Laitinen T (2019) Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients. Sleep Breath 2019. https://doi.org/10.1007/s11325-019-01808-4

  2. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA, for the CHARM investigators (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366:2005–2011

  3. Curtis JR, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, Judd S, Safford M, Solomon DH, Lacroix AZ (2011) Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials. Med Care 49:427–435

    Article  Google Scholar 

  4. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW (2009) Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 64:939–943

    Article  CAS  Google Scholar 

Download references

Disclaimer

The views in this letter are solely those of the author and do not reflect the views of the US Government, Department of Veterans Affairs, Minneapolis Veterans Affairs Health Care System, or the University of Minnesota.

Author information

Authors and Affiliations

  1. Pulmonary and Sleep Medicine (111N), Minneapolis Veterans Affairs Health Care System, University of Minnesota, One Veterans Drive, Minneapolis, MN, 55417, USA

    Ken M. Kunisaki

Authors
  1. Ken M. Kunisaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken M. Kunisaki.

Ethics declarations

Conflict of interest

K. Kunisaki reports having previously served as a consultant to GlaxoSmithKline in 2018, and current receipt of funding from the US National Institutes of Health for sleep-related research (R01 HL131049).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kunisaki, K.M. CPAP adherence and cardiovascular disease: beware of the healthy adherer effect. Sleep Breath 24, 599–600 (2020). https://doi.org/10.1007/s11325-019-01849-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-019-01849-9

Search

Navigation